Ke Ding;Chiwai Wong;Lijie Peng;Xi Zhou;Zhanfang Kang
发明人:
Ke Ding,Chiwai Wong,Lijie Peng,Zhanfang Kang,Xi Zhou
申请号：
US13054664
公开号：
US08853221B2
申请日:
2009.03.06
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The compounds according to formula (VIII), their pharmaceutically acceptable acid or base addition salts, and the uses thereof. These compounds and their pharmaceutically acceptable acid or base addition salts can be used for preparing medicaments for modulating estrogen related receptors (ERR), and treating metabolic diseases, such as high blood fat, fatty liver, hyperglycemia, diabetes, obesity. The substituents of the formula are defined in the description.
